4.8 Review

Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2

Sam Afkhami et al.

Summary: The study found that using adenoviral vectors with a multivalent vaccine through intranasal immunization can generate better mucosal immune responses, including local and systemic antibody responses, mucosal tissue-resident memory T cells, and mucosal trained innate immunity, and provide protection against multiple viral variants.
Article Engineering, Environmental

Zwitterionic polydopamine modified nanoparticles as an efficient nanoplatform to overcome both the mucus and epithelial barriers

Shanshan Hu et al.

Summary: The study demonstrates that PDA-modified PLGA nanoparticles can rapidly penetrate mucus and enhance cellular uptake, showing significant potential for oral drug delivery application.

CHEMICAL ENGINEERING JOURNAL (2022)

Review Chemistry, Multidisciplinary

Bridging micro/nano-platform and airway allergy intervention

Meng-Jie Sun et al.

Summary: Allergic airway diseases are increasingly prevalent due to industrial development and environmental degradation, and current treatments using small molecule chemotherapeutics via intranasal route have inherent limitations. Intratracheal micro/nano therapeutic systems are emerging as innovative alternatives, improving drug therapy for respiratory allergies and offering potential application directions in carriers, therapeutic agents, and immunomodulators. Despite being a growing area, micro/nano therapeutic systems show promise as crucial future alternatives for allergic airway inflammation interventions.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Otorhinolaryngology

The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines

Yuichi Kurono

Summary: The mucosal immune system prevents microorganism invasion through mucosal surfaces and intranasal vaccines can prevent upper respiratory infections. Mucosal adjuvants have been developed to enhance immune responses to intranasal antigens. Phosphorylcholine (PC) has demonstrated significant effects as a mucosal vaccine through intranasal immunization.

AURIS NASUS LARYNX (2022)

Article Engineering, Multidisciplinary

Tailoring functional nanoparticles for oral vaccine delivery: Recent advances and future perspectives

Pei Cao et al.

Summary: This review summarizes the advances and challenges of functional nanoparticles and nanocomposites in oral vaccine delivery, including the barriers of mucosal delivery, transport mechanisms, and physicochemical properties. Various nanoformulations are exemplified.

COMPOSITES PART B-ENGINEERING (2022)

Article Chemistry, Multidisciplinary

Development of allergic rhinitis immunotherapy using antigen-loaded small extracellular vesicles

Wen Liu et al.

Summary: In this study, small extracellular vesicles (sEVs) were used as delivery carriers for allergens and CpG DNA to treat allergic rhinitis. Administration of CpG-OVA-sEVs successfully altered the Th1/Th2 balance, alleviated allergic symptoms, and reduced IgE secretion.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Multidisciplinary Sciences

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Tirosh Shapira et al.

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus is still a global public health crisis, with reduced efficacy of vaccination campaigns due to emerging variants of concern. Development of host-directed therapeutics and prophylactics can limit resistance and provide urgently needed protection against these variants.

NATURE (2022)

Article Multidisciplinary Sciences

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Junyu Chen et al.

Summary: Significant progress has been made in the development of intramuscular vaccines against SARS-CoV-2, but they have limitations in eliciting local immunity in the respiratory tract. To overcome this, researchers have constructed a nasal vaccine candidate using an influenza vector that contains the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. Preclinical studies have shown that this vaccine candidate provides protection against lung pathology and demonstrates cross-protection against SARS-CoV-2 variants and other influenza viruses.

SCIENCE BULLETIN (2022)

Article Engineering, Biomedical

Self-assembled flagella protein nanofibers induce enhanced mucosal immunity

Duo Fu et al.

Summary: This study investigated the interaction between nanofibers and the mucosal interface, as well as the impact of nanofiber length on immune responses. The results showed that shorter nanofibers had a stronger ability to activate immune responses and enhance mucosal and systematic antibody responses. Additionally, vaccines adjuvanted with shorter nanofibers were able to induce cytotoxic T lymphocyte responses, effectively inhibiting tumor growth.

BIOMATERIALS (2022)

Article Biotechnology & Applied Microbiology

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

Felicia Scaggs Huang et al.

Summary: The study demonstrated that SeVRSV vaccine was well-tolerated in healthy adults with only mild to moderate reactions and no severe adverse events. Transient vaccine genome detection was observed due to preexisting immunity towards hPIV-1 and RSV in adults. Minimal antibody responses to SeV and negligible responses to RSV F were observed.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Review Pharmacology & Pharmacy

Advanced oral vaccine delivery strategies for improving the immunity q

Yuandong Zhang et al.

Summary: Infectious diseases continue to be a significant global health burden, with vaccination seen as the most effective way to combat them. Despite the unique advantages of oral vaccines, there are challenges in adapting them for effective delivery. Innovative delivery techniques show promise in improving the effectiveness of oral vaccines.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Chemistry, Applied

Immunostimulatory effect of N-2-hydroxypropyltrimethyl ammonium chloride chitosan-sulfate chitosan complex nanoparticles on dendritic cells

Chaojie Xu et al.

Summary: The study synthesized chitosan derivative nanoparticles with positive and negative charges, evaluated their characteristics and immunostimulatory effects on dendritic cells. The findings suggest that these nanoparticles have the potential to serve as immunological adjuvants.

CARBOHYDRATE POLYMERS (2021)

Review Biochemistry & Molecular Biology

COVID-19 vaccines: where we stand and challenges ahead

Guido Forni et al.

Summary: The development of vaccines has made significant progress, but still faces various challenges, including different target populations, immunological adaptability of vaccines, and production and distribution issues. To ensure equitable access, protection of diverse subjects, and immunity against viral variants, multiple vaccines may be needed in the long run.

CELL DEATH AND DIFFERENTIATION (2021)

Article Multidisciplinary Sciences

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis

Christina Krienke et al.

Summary: The study demonstrates the potential use of modified m1 Psi mRNA in the treatment of multiple sclerosis, showing its ability to suppress the disease, promote the development of T-reg cell populations, and enhance bystander immunosuppression.

SCIENCE (2021)

Article Pharmacology & Pharmacy

Intranasal vaccine: Factors to consider in research and development

Haiyue Xu et al.

Summary: There are currently only a few intranasal vaccines approved for human use, mainly live attenuated influenza virus vaccines. Challenges exist in developing intranasal vaccines, including unique formulation considerations, the need for safe and effective mucosal vaccine adjuvants, and improved vaccine application devices. Preclinical animal models that can better predict intranasal vaccine performance in clinical trials are also crucial to increasing the success rate of intranasal vaccines.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Chemistry, Multidisciplinary

Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2

Kyung Soo Park et al.

Summary: The study introduces a new lipid-based nanoparticle vaccine platform that effectively presents viral proteins to induce antibody responses and promotes dendritic cell uptake. Using this platform successfully induced neutralizing antibody responses against HIV-1 and SARS-CoV-2.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Chemistry, Medicinal

Poly(hydrophobic amino acid)-Based Self-Adjuvanting Nanoparticles for Group A Streptococcus Vaccine Delivery

Armira Azuar et al.

Summary: The study demonstrates the potential of self-adjuvanting poly(hydrophobic amino acids) as a delivery system for peptide-based vaccines against Group A Streptococcus (GAS). Conjugates with a linear arrangement of J8-PADRE and leucine were found to induce equally effective or even better immune responses compared to commercial adjuvants. The developed adjuvant-free vaccine based on single molecule successfully elicited antibodies capable of killing GAS bacteria.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Immunology

Co-delivery of PSMA antigen epitope and mGM-CSF with a cholera toxin-like chimeric protein suppressed prostate tumor growth via activating dendritic cells and promoting CTL responses

Danmin Lin et al.

Summary: A chimeric protein resembling cholera toxin was developed in this study and shown to effectively induce immune responses against prostate tumor cells. The fusion protein could trigger the maturation of dendritic cells and enhance CTL responses, suggesting its potential for future clinical anti-tumoral applications.

VACCINE (2021)

Review Pharmacology & Pharmacy

Current Perspective on Nasal Delivery Systems for Chronic Rhinosinusitis

Junhu Tai et al.

Summary: Chronic rhinosinusitis is commonly treated with topical drugs delivered through the nasal cavity. In addition to traditional medications, research is ongoing to explore novel topical agents. The effectiveness of nasal drug delivery is influenced by various factors related to fluid dynamics in the nasal cavity, highlighting the need for consideration of these factors.

PHARMACEUTICS (2021)

Review Pharmacology & Pharmacy

Target specific tight junction modulators

Joel Brunner et al.

Summary: Research focuses on modulating intercellular tight junctions to enhance drug absorption and bioavailability, with challenges in commercialization. Target-specific permeation enhancers have potential clinical applications.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Allergy

Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis

Charlene C. Ng et al.

Summary: Loratadine-pseudoephedrine tablet (LP) showed significantly greater improvement in nasal airflow compared to fluticasone propionate nasal spray (FP) and placebo in treating allergic rhinitis symptoms. FP did not demonstrate the same benefit as LP in this study.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Review Infectious Diseases

The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review

Jing Shan et al.

Summary: This systematic review analyzed RSV vaccine clinical trials from 2000 to 2020 and identified promising vaccine candidates for infants, children, and the elderly. Live-attenuated and nanoparticle vaccines showed potential efficacy, while a promising maternal vaccine candidate is still lacking.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)

Review Pharmacology & Pharmacy

Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?

Mattia Tiboni et al.

Summary: All currently marketed SARS-CoV-2 vaccines are administered intramuscularly and provide significant efficacy in preventing viremia and the COVID-19 syndrome, but offer limited protection against viral replication and shedding in the upper airways, potentially allowing for transmission from vaccinated individuals. Novel nasal COVID-19 vaccines in development may induce a more comprehensive immune response, including mucosal immunity, and hold promise for preventing viral replication and shedding in respiratory tracts.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Immunology

Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine

Yinyan Yin et al.

Summary: Intranasal immunization with riboflavin as a mucosal adjuvant enhances mucosal immunity and systemic immune response for H1N1 WIV, while also improving the protection level against lethal influenza challenge. Riboflavin has the potential to induce dendritic cell maturation and cytokine secretion, and activates the MAPK signaling pathway, suggesting it as a promising mucosal adjuvant for influenza nasal vaccine.

VACCINES (2021)

Review Immunology

mRNA vaccines manufacturing: Challenges and bottlenecks

Sara Sousa Rosa et al.

Summary: mRNA vaccines are emerging as a new alternative to conventional vaccines, with their precision, safety profile, and flexible manufacturing. They have been used to combat the Covid-19 pandemic and are being studied for other diseases as well. However, challenges in manufacturing, technology platform, and cost-effective production need to be addressed to fully utilize this new vaccination technology.

VACCINE (2021)

Review Medicine, General & Internal

Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines

Bogdan Doroftei et al.

Summary: After analyzing 19 relevant articles, it was concluded that among the eleven vaccines, Pfizer-BioNTech (about 95%), Moderna (about 94%), and Sputnik V (about 92%) showed an efficacy greater than 90%, while Oxford-AstraZeneca was only about 81% effective. Additionally, Moderna, Sputnik V, and Oxford-AstraZeneca also reduced the occurrence of severe adverse reactions.

DIAGNOSTICS (2021)

Review Pharmacology & Pharmacy

Methods to improve the immunogenicity of plasmid DNA vaccines

Dalinda Eusebio et al.

Summary: DNA vaccines are innovative approaches that show great potential in overcoming the limitations of traditional vaccines. While plasmid DNA vaccines have numerous advantages, there are still challenges in improving their immunogenicity.

DRUG DISCOVERY TODAY (2021)

Review Pharmacology & Pharmacy

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management

Vivek P. Chavda et al.

Summary: Intranasal vaccines have advantages in targeting SARS-CoV-2 infection, eliciting immune responses, and avoiding infections, while also convenient for self-administration and storage at ambient temperatures.

DRUG DISCOVERY TODAY (2021)

Review Pharmacology & Pharmacy

Progress in nasal drug delivery systems

Flavia Laffleur et al.

Summary: Nasal drug delivery systems, serving as alternatives to oral or injection administration, offer advantages such as ease of use, high drug concentration, masking of unpleasant taste, and suitability for local and systemic use. They have gained importance in the past five years.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Chemistry, Multidisciplinary

Chitosan-centered nanosystems as sustained therapeutics for allergic rhinitis intervention: Inhibition of histamine-induced cascades

Mengjie Sun et al.

Summary: Nanosystems incorporating ketotifen and cetirizine show longer histamine release inhibition and histamine H1 receptor antagonism, providing better therapeutic efficacy for respiratory allergy intervention.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Microbiology

Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection

Minami Nagai et al.

Summary: Disruption of nasal bacteria enhances virus-specific antibody response, possibly by releasing bacterial components that stimulate the immune system. Supplementing oral bacteria can enhance the efficacy of intranasal vaccines, as nasal bacteria levels are lower compared to oral bacteria.
Article Pharmacology & Pharmacy

Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa

Lena Marie Spindler et al.

Summary: The study demonstrates the potential of PLGA nanoparticles and chitosan NiMPs to utilize all three prominent intranasal delivery pathways to the brain and the CNS: transcellular, intracellular via neuronal cells, and paracellular transport. The findings suggest that these nanoparticles and microparticles hold promise for the treatment of neurological diseases.

FRONTIERS IN PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery

Emanuela Fabiola Craparo et al.

Summary: Neurodegenerative diseases pose challenges in treatment and diagnosis, prompting research on nanoformulations for intranasal delivery to target the brain by bypassing the BBB. The fluorescent PNPs produced were found suitable for studying cellular trafficking for nose-to-brain drug delivery.

PHARMACEUTICS (2021)

Review Immunology

Mucosal vaccines: wisdom from now and then

Hiroshi Kiyono et al.

Summary: The mucosal immune system in the oral and nasal cavities plays a crucial role in recognizing pathogens and initiating immune responses. Dental science has been a key driving force in studying mucosal immunity and developing mucosal vaccines for oral infectious diseases. Mucosal immunology and vaccines have now become significant entities in the discipline of immunology.

INTERNATIONAL IMMUNOLOGY (2021)

Review Immunology

A guide to vaccinology: from basic principles to new developments

Andrew J. Pollard et al.

Summary: Immunization is vital for public health policy and there are challenges ahead for immunologists in developing new vaccines. Although immunology has not contributed significantly to vaccine development so far, a better understanding of protective immunity is urgently needed to tackle difficult-to-target pathogens.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Immunology

Global oral cholera vaccine use, 2013-2018

Lorenzo Pezzoli et al.

VACCINE (2020)

Review Chemistry, Multidisciplinary

Immunology-Guided Biomaterial's Design as Mucosal Cancer Vaccine

Shiran Ferber et al.

ADVANCED MATERIALS (2020)

Article Chemistry, Multidisciplinary

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune-Adjuvant

Tao Qin et al.

ADVANCED SCIENCE (2020)

Article Immunology

Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity

Omkar Chaudhary et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2020)

Article Public, Environmental & Occupational Health

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

Sara E. Oliver et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Infectious Diseases

Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine

Ian Shannon et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

Review Chemistry, Multidisciplinary

Nanoparticle formulated vaccines: opportunities and challenges

Pingsai Lung et al.

NANOSCALE (2020)

Review Immunology

Mucosal vaccines and technology

A. Miquel-Clopes et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

Review Chemistry, Multidisciplinary

Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization

Ning Wang et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Review Biochemistry & Molecular Biology

Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery

Areen Alshweiat et al.

CURRENT MEDICINAL CHEMISTRY (2019)

Article Pharmacology & Pharmacy

Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination

Genada Sinani et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Review Pharmacology & Pharmacy

Nasal route for vaccine and drug delivery: Features and current opportunities

Yadira Lobaina Mato

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Article Chemistry, Multidisciplinary

Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy

Gulsah Erel-Akbaba et al.

ACS NANO (2019)

Review Immunology

Nanoparticle-Based Vaccines Against Respiratory Viruses

Soultan Al-Halifa et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Pediatrics

Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery

Neha Garg et al.

INDIAN JOURNAL OF PEDIATRICS (2018)

Review Pharmacology & Pharmacy

Intranasal immunization with dry powder vaccines

Tania F. Bahamondez-Canas et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)

Review Medicine, Research & Experimental

Mechanism of intranasal drug delivery directly to the brain

Tyler P. Crowe et al.

LIFE SCIENCES (2018)

Review Biochemistry & Molecular Biology

Nanogel-based nasal vaccines for infectious and lifestyle-related diseases

Tatsuhiko Azegami et al.

MOLECULAR IMMUNOLOGY (2018)

Article Nanoscience & Nanotechnology

Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity

Chao Wang et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Review Biotechnology & Applied Microbiology

Noninvasive vaccination against infectious diseases

Zhichao Zheng et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Review Immunology

Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance

Takashi Kei Kishimoto et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Pharmacology & Pharmacy

The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1

Mona Kabiri et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Pharmacology & Pharmacy

Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles

F. Lebre et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Review Allergy

Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy

Martina Anzaghe et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2018)

Article Pharmacology & Pharmacy

Robust mucosal and systemic responses against HTLV-1 by delivery of multiepitope vaccine in PLGA nanoparticles

Mona Kabiri et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)

Review Chemistry, Multidisciplinary

Biomaterials for vaccine-based cancer immunotherapy

Rui Zhang et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Article Chemistry, Medicinal

A Perspective on Nanoparticle Universal Influenza Vaccines

Lei Deng et al.

ACS INFECTIOUS DISEASES (2018)

Review Immunology

Development of a nanogel-based nasal vaccine as a novel antigen delivery system

Rika Nakahashi-Ouchida et al.

EXPERT REVIEW OF VACCINES (2017)

Article Surgery

Nasal Anatomy and Function

Ruchin G. Patel

FACIAL PLASTIC SURGERY (2017)

Review Pharmacology & Pharmacy

Nasal nanovaccines

B. Bernocchi et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Article Pharmacology & Pharmacy

Nasal vaccination with poly(β-amino ester)-poly(D,L-lactide-co-lycolide) hybrid nanoparticles

Genada Sinani et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Article Pharmacology & Pharmacy

PEGylated composite nanoparticles of PLGA and polyethylenimine for safe and efficient delivery of pDNA to lungs

Atul Kolte et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Article Pharmacology & Pharmacy

Protease-functionalized mucus penetrating microparticles: In-vivo evidence for their potential

Arshad Mahmood et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Article Pharmacology & Pharmacy

Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination

F. Lebre et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)

Review Instruments & Instrumentation

Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals

Daniella Calderon-Nieva et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2017)

Review Pharmacology & Pharmacy

Current state and challenges in developing oral vaccines

Julia E. Vela Ramirez et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Review Chemistry, Medicinal

Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery

Sara Salatin et al.

ARCHIVES OF PHARMACAL RESEARCH (2016)

Review Pharmacology & Pharmacy

Mucoadhesive vs. mucopenetrating particulate drug delivery

Kesinee Netsomboon et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)

Article Pharmacology & Pharmacy

Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses

Zhaoyan Zeng et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)

Article Chemistry, Multidisciplinary

Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles

B. Bernocchi et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Biochemistry & Molecular Biology

The evolution of nasal immune systems in vertebrates

Ali Sepahi et al.

MOLECULAR IMMUNOLOGY (2016)

Review Biotechnology & Applied Microbiology

Intradermal vaccination for infants and children

Akihiko Saitoh et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)

Article Pharmacology & Pharmacy

Mucus permeating thiomer nanoparticles

S. Koellner et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)

Review Pharmacology & Pharmacy

Nano-carrier systems: Strategies to overcome the mucus gel barrier

S. Duennhaupt et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)

Review Pharmacology & Pharmacy

Nasal and pulmonary vaccine delivery using particulate carriers

Yimei Jia et al.

EXPERT OPINION ON DRUG DELIVERY (2015)

Article Chemistry, Multidisciplinary

Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach

Fabrice Rose et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Article Chemistry, Multidisciplinary

Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens

Yuchen Fan et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Article Chemistry, Applied

Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: in vivo studies

Erdal Cevher et al.

JOURNAL OF MICROENCAPSULATION (2015)

Article Immunology

Development of an AIDS vaccine using Sendai virus vectors

Hiroshi Ishii et al.

VACCINE (2015)

Article Chemistry, Medicinal

Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery

Keon-Hyoung Song et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2015)

Review Immunology

Induction of Intestinal Immunity by Mucosal Vaccines As a Means of Controlling HIV Infection

Jordan Poles et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)

Article Pharmacology & Pharmacy

N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitro

Berglind Eva Benediktsdottir et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)

Review Pharmacology & Pharmacy

Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules

Ana Fortuna et al.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)

Review Chemistry, Multidisciplinary

Chitosan in nasal delivery systems for therapeutic drugs

Luca Casettari et al.

JOURNAL OF CONTROLLED RELEASE (2014)

Review Public, Environmental & Occupational Health

Review of Influenza A Virus in Swine Worldwide: A Call for Increased Surveillance and Research

A. Vincent et al.

ZOONOSES AND PUBLIC HEALTH (2014)

Article Chemistry, Multidisciplinary

Polymer Nanomicelles for Efficient Mucus Delivery and Antigen-Specific High Mucosal Immunity

Young-Woock Noh et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

Review Immunology

Antigen sampling in the small intestine

Olga Schulz et al.

TRENDS IN IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

Establishment of Nasal Tolerance to Heat Shock Protein-60 Alleviates Atherosclerosis by Inducing TGF-β-dependent Regulatory T Cells

Haiyu Li et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2012)

Article Medicine, Research & Experimental

Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein

Dharmendra Raghuwanshi et al.

MOLECULAR PHARMACEUTICS (2012)

Article Biotechnology & Applied Microbiology

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

Frank Wegmann et al.

NATURE BIOTECHNOLOGY (2012)

Review Polymer Science

PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications

Luca Casettari et al.

PROGRESS IN POLYMER SCIENCE (2012)

Review Immunology

Devices for intradermal vaccination

Elsa E. Kis et al.

VACCINE (2012)

Article Chemistry, Multidisciplinary

Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery

Thejani E. Rajapaksa et al.

JOURNAL OF CONTROLLED RELEASE (2010)

Article Chemistry, Physical

Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines

Tomonori Nochi et al.

NATURE MATERIALS (2010)

Article Infectious Diseases

Are there differences in immunogenicity and safety of vaccines according to the injection method?

F. Ajana et al.

MEDECINE ET MALADIES INFECTIEUSES (2008)

Review Cell Biology

Alternative routes of mucosal immunization in large animals

BJ Sedgmen et al.

IMMUNOLOGY AND CELL BIOLOGY (2004)

Article Biochemistry & Molecular Biology

The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line

G Ranaldi et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2002)